Evidence map›Paper›PMID 25371358›Full record

ReviewDevelopment (Cambridge, England)2014

Stem cells and the impact of ROS signaling.

Carolina L Bigarella, Raymond Liang, Saghi Ghaffari

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06108388 (Functional Investigation of Endothelial Function and Regenerative Cell Exhaustion in Type 2 Diabetes), which is not on this map. Cited by 335 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
335citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06108388 unknown statusnot on this mapstarted 2023, after this paper: background citation

Functional Investigation of Endothelial Function and Regenerative Cell Exhaustion in Type 2 Diabetes

TypeobservationalSponsorCanadian Medical and Surgical Knowledge Translation Research GroupRan2023 to 2026Enrolled90ConditionsDiabetes Mellitus, Type 2
3 · Its place in the literature

Who cites it

335 citing papers in PubMed, 1 synthesis or guideline pooled it, 615 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antioxidants (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Article
  14. MK4 Repositioning for IAHSP: OvercomingACS chemical neuroscience · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

275 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Carolina L BigarellaDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Raymond LiangDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Developmental and Stem Cell Biology, Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Saghi GhaffariDepartment of Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Developmental and Stem Cell Biology, Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Department of Medicine, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA saghi.ghaffari@mssm.edu.
Icahn School of Medicine at Mount Sinai · US

Funding

Interdisciplinary Training in Systems and Developmental Biology and Birth DefectsT32HD075735 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JABS, ETHYLIN WANG · 2013 to 2022
$1.8M
NICHD NIH HHS T32 HD075735
6 · The paper itself

Abstract

An appropriate balance between self-renewal and differentiation is crucial for stem cell function during both early development and tissue homeostasis throughout life. Recent evidence from both pluripotent embryonic and adult stem cell studies suggests that this balance is partly regulated by reactive oxygen species (ROS), which, in synchrony with metabolism, mediate the cellular redox state. In this Primer, we summarize what ROS are and how they are generated in the cell, as well as their downstream molecular targets. We then review recent findings that provide molecular insights into how ROS signaling can influence stem cell homeostasis and lineage commitment, and discuss the implications of this for reprogramming and stem cell ageing. We conclude that ROS signaling is an emerging key regulator of multiple stem cell populations.

Indexed as

AnimalsCell DifferentiationCell ProliferationHomeostasisHumansOxidation-ReductionReactive Oxygen SpeciesSignal TransductionStem CellsReactive Oxygen SpeciesEmbryonic stem cellsHematopoietic stem cellsMetabolismMitochondriaROS

Identifiers

PMID25371358
PMCPMC4302918
OpenAlexW2011074645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.